Bio-Techne Corp (TECH)
Total asset turnover
Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 1,219,634 | 1,208,768 | 1,196,015 | 1,171,582 | 1,159,059 | 1,154,281 | 1,144,999 | 1,143,982 | 1,136,702 | 1,123,611 | 1,119,841 | 1,117,536 | 1,105,600 | 1,076,399 | 1,029,575 | 984,552 | 931,032 | 847,838 | 798,966 | 759,647 |
Total assets | US$ in thousands | 2,557,870 | 2,644,260 | 2,670,420 | 2,736,020 | 2,813,190 | 2,721,170 | 2,730,750 | 2,755,360 | 2,638,690 | 2,599,700 | 2,363,400 | 2,350,720 | 2,294,800 | 2,299,890 | 2,304,850 | 2,270,190 | 2,262,960 | 2,084,640 | 2,067,870 | 2,053,100 |
Total asset turnover | 0.48 | 0.46 | 0.45 | 0.43 | 0.41 | 0.42 | 0.42 | 0.42 | 0.43 | 0.43 | 0.47 | 0.48 | 0.48 | 0.47 | 0.45 | 0.43 | 0.41 | 0.41 | 0.39 | 0.37 |
June 30, 2025 calculation
Total asset turnover = Revenue (ttm) ÷ Total assets
= $1,219,634K ÷ $2,557,870K
= 0.48
The total asset turnover ratio for Bio-Techne Corp has exhibited a generally upward trend from September 30, 2020, through June 30, 2025. Starting at 0.37 in September 2020, it progressively increased over subsequent periods, peaking at 0.48 in June 2022 and June 2025. Throughout this period, the ratio demonstrated a steady improvement in the company's efficiency in utilizing its total assets to generate sales, indicating enhanced operational effectiveness or strategic asset management.
Following a relatively stable phase around 0.48 from June 2022 to September 2022, the ratio experienced a slight decline in the latter part of 2022, dropping to 0.42 by the end of December 2022. Subsequently, the ratio fluctuated marginally around this level, with minor increases reaching 0.46 and 0.48 in the most recent periods.
Overall, the trajectory suggests that Bio-Techne has been improving its asset utilization over time. The incremental increases indicate a positive trend in operational efficiency, while the brief declines and fluctuations may reflect temporary adjustments, market conditions, or operational shifts. The current ratios remain relatively stable around the 0.42 to 0.48 range, underscoring a consistent level of asset productivity in recent periods.
Peer comparison
Jun 30, 2025